申请人:Synthetic Biologics, Inc.
公开号:US20190277833A1
公开(公告)日:2019-09-12
The present invention relates, in part, to treatment of various diseases and disorders such as GI disorders through modulation of F420-dependent enzymes including specific enzymes involved in methanogenesis.